Compare PLOW & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLOW | IVA |
|---|---|---|
| Founded | 1948 | 2011 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 895.3M |
| IPO Year | 2010 | 2020 |
| Metric | PLOW | IVA |
|---|---|---|
| Price | $39.45 | $3.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $51.50 | $16.20 |
| AVG Volume (30 Days) | 130.0K | ★ 1.3M |
| Earning Date | 05-04-2026 | 03-30-2026 |
| Dividend Yield | ★ 2.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $656,053,000.00 | N/A |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $5.36 | $751.20 |
| P/E Ratio | $29.99 | ★ N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $28.52 | $3.35 |
| 52 Week High | $55.00 | $7.98 |
| Indicator | PLOW | IVA |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | N/A |
| Support Level | $38.69 | N/A |
| Resistance Level | $42.84 | N/A |
| Average True Range (ATR) | 0.89 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 27.10 | 0.00 |
Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.